ILLUMINA, INC.

ILMN
Delayed Quote. Delayed  - 09/18 04:00:00 pm
295.5USD -0.85%
Prev.298.0200
Open298.3600
High300.9200
Low290.8300
Volume5 365 869
Latest news
3d ago
5d ago
09/09
09/09
Chart ILLUMINA, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralNeutral
Resistance328401384
Spread/Res.-9,8%-26%-23%
Spread/Supp.2,5%24%27%
Support288238233
Financials
Sales 2020 3 098 M - -
Net income 2020 529 M - -
Net cash 2020 2 332 M - -
P/E ratio 2020 85,7x
Yield 2020 -
Capitalization 43 143 M 43 143 M -
EV / Sales 2020 13,2x
EV / Sales 2021 10,1x
Nbr of Employees 7 700
Free-Float 75,0%
Company
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations,...

>> Read more
Sector :
Advanced Medical Equipment & Technology - NEC
Calendar :
2020-10-27 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 346,56 $
Last Close Price 295,50 $
Spread / Highest target 35,4%
Spread / Average Target 17,3%
Spread / Lowest Target -25,5%